Peter O’Donnell
Finance and Building Operations Manager
News
-
New grant targets longer-lasting islet cell treatments for type 1 diabetes
Dr Lise Hunault, a researcher in the Centenary Institute’s Centre for Biomedical AI, has been awarded a major research grant from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organisation, to advance islet-cell replacement therapies for type 1 diabetes.Date
-
Centenary marks International Women’s Day with inspiring speakers
The Centenary Institute community came together to celebrate International Women’s Day 2026, with a special event highlighting this year’s Australian theme, ‘Balancing the Scales.’Date -
Vaxosome launched to develop next-generation mRNA vaccines
A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.Date
